Latest Articles

Publication Date
Essex teen says endometriosis shouldn't be 'taboo' as she shares her story - Clacton and Frinton Gazette

Essex teen says endometriosis shouldn't be 'taboo' as she shares her story Clacton and Frinton Gazette

Published: Dec. 4, 2024, 9:01 a.m.
Karyopharm Therapeutics Provides Regulatory Update on Endometrial Cancer ProgramOn December 3, 2024, Karyopharm Therapeutics Inc. released a press statement outlining a regulatory update on its endometrial cancer program. This update comes in li - Defense World

Karyopharm Therapeutics Provides Regulatory Update on Endometrial Cancer ProgramOn December 3, 2024, Karyopharm Therapeutics Inc. released a press statement outlining a regulatory update on its endometrial cancer program. This update …

Published: Dec. 4, 2024, 8:10 a.m.
Endometriosis, fibroids and heavy periods: long-term research supports treatment decisions - NIHR Evidence

Endometriosis, fibroids and heavy periods: long-term research supports treatment decisions NIHR Evidence

Published: Dec. 4, 2024, 8 a.m.
Endometriosis: ‘It’s so frustrating and isolating to know there’s something wrong with your body but to not be believed’ - The Irish Times

Endometriosis: ‘It’s so frustrating and isolating to know there’s something wrong with your body but to not be believed’ The Irish Times

Published: Dec. 4, 2024, 6:02 a.m.
Endometriosis: ‘If I was believed 10 years ago, maybe it wouldn’t be this extensive’ - The Irish Times

Endometriosis: ‘If I was believed 10 years ago, maybe it wouldn’t be this extensive’ The Irish Times

Published: Dec. 4, 2024, 6:02 a.m.
What is Visanne, the endometriosis drug just added to the PBS? - New Zealand Doctor Online

What is Visanne, the endometriosis drug just added to the PBS? New Zealand Doctor Online

Published: Dec. 4, 2024, 1:33 a.m.
NMPA greenlights new endometrial cancer therapy - Investing.com India

NMPA greenlights new endometrial cancer therapy Investing.com India

Published: Dec. 4, 2024, 1:01 a.m.
Innovent & HUTCHMED Win China Approval for Breakthrough Endometrial Cancer Therapy | IVBIY Stock News - StockTitan

Innovent & HUTCHMED Win China Approval for Breakthrough Endometrial Cancer Therapy | IVBIY Stock News StockTitan

Published: Dec. 4, 2024, 12:01 a.m.
Innovent & HUTCHMED Win China Approval for Breakthrough Endometrial Cancer Therapy | HCM Stock News - StockTitan

Innovent & HUTCHMED Win China Approval for Breakthrough Endometrial Cancer Therapy | HCM Stock News StockTitan

Published: Dec. 4, 2024, midnight
Receptive window might be shorter in patients with endometriosis and lesions cyclically prepare for implantation.

To investigate whether endometrial receptivity is affected in patients with endometriosis using podocalyxin (PCX) as a functional biomarker; to study how endometriotic lesions display PCX and the potential pathological implications.

Published: Dec. 4, 2024, midnight
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!